LWM
CVS icon

Laidlaw Wealth Management’s CVS Health CVS Stock Holding History

Laidlaw Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,784
Closed -$299K – 191
2023
Q4 		$299K Sell
3,784
-99
-3% -$7.05K 0.11% 185
2023
Q3 		$271K Sell
3,883
-2,756
-42% -$195K 0.09% 208
2023
Q2 		$459K Sell
6,639
-202
-3% -$14.4K 0.09% 206
2023
Q1 		$508K Sell
6,841
-49
-0.7% -$4.11K 0.1% 200
2022
Q4 		$642K Sell
6,890
-67
-1% -$6.46K 0.14% 165
2022
Q3 		$663K Sell
6,957
-248
-3% -$24.5K 0.15% 151
2022
Q2 		$668K Sell
7,205
-4,014
-36% -$392K 0.14% 163
2022
Q1 		$1.14M Buy
11,219
+188
+2% +$19.8K 0.19% 131
2021
Q4 		$1.14M Buy
+11,031
New +$1.02M 0.18% 134
2021
Q1 		– Sell
-14,251
Closed -$973K – 247
2020
Q4 		$973K Buy
14,251
+1,385
+11% +$90.1K 0.2% 123
2020
Q3 		$751K Sell
12,866
-2,038
-14% -$127K 0.33% 84
2020
Q2 		$968K Sell
14,904
-1,059
-7% -$66.7K 0.51% 65
2020
Q1 		$947K Sell
15,963
-1,283
-7% -$85.6K 0.62% 57
2019
Q4 		$1.28M Buy
+17,246
New +$1.21M 0.81% 40

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Laidlaw Wealth Management's CVS Position: Q1 2024 in Review

Laidlaw Wealth Management sold out of CVS Health (CVS) in Q1 2024, closing a stake of 3,784 shares — an estimated $299K sold.

Laidlaw Wealth Management first reported a position in CVS in Q4 2019 and held it in 14 quarters. The position peaked at $1.28M in Q4 2019. 2,176 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

  • Laidlaw Wealth Management reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
  • Laidlaw Wealth Management sold 3,784 CVS Health shares in Q1 2024, an estimated $299K.
  • Laidlaw Wealth Management first reported a position in CVS Health in Q4 2019 and held it in 14 quarters.
  • Laidlaw Wealth Management's CVS Health position peaked at $1.28M in Q4 2019.
  • 2,176 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Laidlaw Wealth Management's 13F filing for Q1 2024, filed 15 May 2024.